{"organizations": [], "uuid": "a1e63f49212d2aadcac09be99af50a11c1cc714c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-biocryst-pharmaceuticals-and-idera/brief-biocryst-pharmaceuticals-and-idera-pharmaceuticals-reschedule-meetings-to-vote-on-proposed-merger-idUSFWN1RN0JK", "country": "US", "domain_rank": 408, "title": "BRIEF-Biocryst Pharmaceuticals And Idera Pharmaceuticals Reschedule Meetings To Vote On Proposed Merger", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-10T14:34:00.000+03:00", "replies_count": 0, "uuid": "a1e63f49212d2aadcac09be99af50a11c1cc714c"}, "author": "", "url": "https://www.reuters.com/article/brief-biocryst-pharmaceuticals-and-idera/brief-biocryst-pharmaceuticals-and-idera-pharmaceuticals-reschedule-meetings-to-vote-on-proposed-merger-idUSFWN1RN0JK", "ord_in_thread": 0, "title": "BRIEF-Biocryst Pharmaceuticals And Idera Pharmaceuticals Reschedule Meetings To Vote On Proposed Merger", "locations": [], "entities": {"persons": [{"name": "idera pharmaceu", "sentiment": "negative"}, {"name": "idera", "sentiment": "none"}, {"name": "idera", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-biocryst pharmaceuticals", "sentiment": "negative"}, {"name": "biocryst", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "idera pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 10, 2018 / 11:37 AM / Updated 5 minutes ago BRIEF-Biocryst Pharmaceuticals And Idera Pharmaceuticals Reschedule Meetings To Vote On Proposed Merger Reuters Staff \nApril 10 (Reuters) - Idera Pharmaceuticals Inc - New Clinical Data On Idera’s Imo : \n* BIOCRYST PHARMACEUTICALS AND IDERA PHARMACEUTICALS RESCHEDULE MEETINGS TO VOTE ON PROPOSED MERGER \n* BIOCRYST AND IDERA SPECIAL MEETINGS TO BE HELD ON JULY 10, 2018 \n* NEW CLINICAL DATA ON IDERA’S IMO-2125 PROGRAM WILL BE AVAILABLE PRIOR TO VOTE \n* IDERA BOARD UNANIMOUSLY RECOMMENDS THAT IDERA STOCKHOLDERS VOTE “FOR” PROPOSED MERGER AT IDERA SPECIAL MEETING Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-10T14:34:00.000+03:00", "crawled": "2018-04-10T14:55:44.000+03:00", "highlightTitle": ""}